Related references
Note: Only part of the references are listed.Cisplatin-Induced Kidney Injury: Delivering the Goods
Joshua N. Curry et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)
Targeted delivery of celastrol to glomerular endothelium and podocytes for chronic kidney disease treatment
Qingsi Wu et al.
NANO RESEARCH (2022)
Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1
Piao Luo et al.
ACTA PHARMACEUTICA SINICA B (2022)
Hepatic TGFβr1 Deficiency Attenuates Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure Through Inhibiting GSK3β-Nrf2-Mediated Hepatocyte Apoptosis and Ferroptosis
Sha Huang et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2022)
Leonurine alleviates ferroptosis in cisplatin-induced acute kidney injury by activating the Nrf2 signalling pathway
Jianqiang Hu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Sirtuin 7 mitigates renal ferroptosis, fibrosis and injury in hypertensive mice by facilitating the KLF15/Nrf2 signaling
Xue-Ting Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2022)
Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications
Brent R. Stockwell
CELL (2022)
Melatonin Alleviates Acute Kidney Injury by Inhibiting NRF2/Slc7a11 Axis-Mediated Ferroptosis
Yue-bo Huang et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)
Ethyl carbamate triggers ferroptosis in liver through inhibiting GSH synthesis and suppressing Nrf2 activation
Yang Xu et al.
REDOX BIOLOGY (2022)
Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes
Dong-Hyun Kim et al.
REDOX BIOLOGY (2022)
Targeted delivery via albumin corona nanocomplex to renal tubules to alleviate acute kidney injury
Shuo Qin et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Signaling pathways of chronic kidney diseases, implications for therapeutics
Qian Yuan et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Quercetin alleviates acute kidney injury by inhibiting ferroptosis
Yue Wang et al.
JOURNAL OF ADVANCED RESEARCH (2021)
Involvement of GPX4 in irisin's protection against ischemia reperfusion-induced acute kidney injury
Jia Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Targeted inhibition of Rev-erb-α/β limits ferroptosis to ameliorate folic acid-induced acute kidney injury
Lianxia Guo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Legumain promotes tubular ferroptosis by facilitating chaperone-mediated autophagy of GPX4 in AKI
Chuan'ai Chen et al.
CELL DEATH & DISEASE (2021)
Panaxydol attenuates ferroptosis against LPS-induced acute lung injury in mice by Keap1-Nrf2/HO-1 pathway
Jiucui Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Celastrol in metabolic diseases: Progress and application prospects
Shaohua Xu et al.
PHARMACOLOGICAL RESEARCH (2021)
Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations
Kristen Renee McSweeney et al.
CANCERS (2021)
Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury
Wulf Tonnus et al.
NATURE COMMUNICATIONS (2021)
Ferroptosis as a novel therapeutic target for cardiovascular disease
Xiaoguang Wu et al.
THERANOSTICS (2021)
Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone-methide triterpenoid celastrol
Yun Lu et al.
MEDICINAL RESEARCH REVIEWS (2021)
Iron overload as a risk factor for hepatic ischemia-reperfusion injury in liver transplantation: Potential role of ferroptosis
Naoya Yamada et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI
Kathleen D. Liu et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2020)
Ferroptosis as a target for protection against cardiomyopathy
Xuexian Fang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation
Dezhong Wang et al.
CELL DEATH & DISEASE (2019)
Myo-inositol oxygenase expression profile modulates pathogenic ferroptosis in the renal proximal tubule
Fei Deng et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Celastrol alleviates renal fibrosis by upregulating cannabinoid receptor 2 expression
Ming Tang et al.
CELL DEATH & DISEASE (2018)
Global epidemiology and outcomes of acute kidney injury
Eric A. J. Hoste et al.
NATURE REVIEWS NEPHROLOGY (2018)
Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-kappa B and improving mitochondrial function
Xiaowen Yu et al.
EBIOMEDICINE (2018)
Mechanisms of ferroptosis
Jennifer Yinuo Cao et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice
Satoko Arai et al.
NATURE MEDICINE (2016)
Biomarkers of AKI: A Review of Mechanistic Relevance and Potential Therapeutic Implications
Joseph L. Alge et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Regulated Cell Death in AKI
Andreas Linkermann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Jose Pedro Friedmann Angeli et al.
NATURE CELL BIOLOGY (2014)
Targeting apoptosis pathways in cancer by Chinese medicine
Min Li-Weber
CANCER LETTERS (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
N. Pabla et al.
KIDNEY INTERNATIONAL (2008)
Molecular understanding and modern application of traditional medicines: Triumphs and trials
Timothy W. Corson et al.
CELL (2007)